KISS1 Antikörper (N-Term)
Kurzübersicht für KISS1 Antikörper (N-Term) (ABIN127218)
Target
Alle KISS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- The antibody recognizes 16 kDa human KiSS-1.
-
Aufreinigung
- Affinity Chromatography.
-
Immunogen
- Synthetic peptide near the N-terminus of Mouse KiSS-1.
-
-
-
-
Applikationshinweise
-
Western Blot: 0.5-4.0 μg/mL. Jurkat cell lysate can be used as a Positive Control.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.2 mg/mL
-
Buffer
- PBS, pH 7.2 containing 30 % Glycerol, 0.5 % BSA and 0.01 % Thimerosal.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C/-80 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- KISS1 (KiSS-1 Metastasis-Suppressor (KISS1))
-
Andere Bezeichnung
- KiSS-1
-
Hintergrund
- KiSS-1 has been reported to suppress metastases of melanomas and breast carcinomas without affecting tumorigenicity. Human KiSS-1 transcripts are predominately expressed in the brain and placenta. Expression of KiSS-1 reduces the level of NFκB p50/p65 binding to the MMP9 promoter and correlates with diminished expression of the 92 kDa type IV collagenase (MMP-9). KiSS-1 may regulate events downstream of cell-matrix adhesion in mechanisms involving cytoskeletal reorganization.Synonyms: KISS1, Metastasis-suppressor KiSS-1, PP5098
-
Gen-ID
- 3814
-
NCBI Accession
- NP_002247
-
UniProt
- Q15726
-
Pathways
- Positive Regulation of Peptide Hormone Secretion
Target
-